Iterum Therapeutics plc (ITRM)
Iterum Names Christine Coyne as Chief Commercial Officer to LeadORLYNVAH™ Launch and Commercial Growth
Avadel Pharmaceuticals (AVDL)
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation
Arvinas Inc (ARVN)
New Form 8-K - ARVINAS, INC. Filed: 2025-06-30 AccNo: 0001655759-25-000128 Size: 157 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders
Aclaris Therapeutics Inc (ACRS)
Oncolytics Biotech Inc (ONCY)
Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
Bausch&Lomb Corp (BLCO)
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
Protalix BioTherapeutics Inc. (PLX)
Protalix BioTherapeutics Added to Russell3000® and 2000 Indexes®
Vicarious Surgical Inc (RBOT)
New Form 8-K - Vicarious Surgical Inc. Filed: 2025-06-30 AccNo: 0001213900-25-059237 Size: 615 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure …
GSK plc (GLAXF)
Vicarious Surgical Inc (RBOT)
Vicarious Surgical Inc. - Vicarious Surgical Announces Election of New Directors
Vicarious Surgical Inc (RBOT)
Vicarious Surgical Announces Election of New Directors